Unlocking Recent Clinical Progress of mRNA-Based Vaccines & B-Cell Depletion Therapies

Time: 9:00 am
day: Conference Day One

Details:

• Demonstrating Abogen’s unique mRNA and LNP platform
• Sharing clinical data and progress of mRNA cancer vaccines
• Accelerating preclinical and clinical development of mRNA-based T-cell engagers and in vivo CAR-T

Speakers:

Bo Ying Dr. Bo Ying is the Chief Executive Officer of Abogen Biosciences, a company focused on delivering transformative therapies through mRNA innovation. He has almost twenty Read more